Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniosis

Vaccine

Volumn 22, Issue 29-30, 2004, Pages 3865-3876

  Iborra, Salvador ^a   Soto, Manuel ^a   Carrión, Javier ^a   Alonso, Carlos ^a   Requena, Jose M ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

DNA vaccines; Histones; Th1 Th2 immune responses

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; DNA VACCINE; GAMMA INTERFERON; HISTONE; IMMUNOGLOBULIN G2A; INTERLEUKIN 12; INTERLEUKIN 4; PLASMID DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EXPERIMENTAL MOUSE; FEMALE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; INTERFERON PRODUCTION; LEISHMANIA INFANTUM; MOUSE; MOUSE STRAIN; NONHUMAN; NUCLEOSOME; PRIORITY JOURNAL; SKIN LEISHMANIASIS; TH1 CELL; VACCINATION;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; HISTONES; IMMUNOGLOBULIN G; INJECTIONS, INTRAMUSCULAR; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-4; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; LYMPH NODES; MICE; MICE, INBRED BALB C; PROTOZOAN PROTEINS; PROTOZOAN VACCINES; SPLEEN; VACCINATION; VACCINES, DNA;

EID: 4444242838     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.04.015     Document Type: Article

References (33)

1. Herwaldt B.L. Leishmaniasis. Lancet. 354(9185):1999;1191-1199
2. Handman E. Leishmaniasis: current status of vaccine development. Clin. Microbiol. Rev. 14(2):2001;229-243
3. Croft S.L., Coombs G.H. Leishmaniasis-current chemotherapy and recent advances in the search for novel drugs. Trends Parasitol. 19(11):2003;502-508
4. Melby P.C. Vaccination against cutaneous leishmaniasis: current status. Am. J. Clin. Dermatol. 3(8):2002;557-570
5. Sacks D., Noben-Trauth N. The immunology of susceptibility and resistance to Leishmania major in mice. Nat. Rev. Immunol. 2(11):2002;845-858
6. Lai W.C., Bennett M. DNA vaccines. Crit. Rev. Immunol. 18(5):1998;449-484
7. Gurunathan S., Klinman D.M., Seder R.A. DNA vaccines: immunology, application, and optimization. Annu. Rev. Immunol. 18:2000;927-974
8. Xu D., Liew F.Y. Genetic vaccination against leishmaniasis. Vaccine. 12(16):1994;1534-1536
9. Gurunathan S., Sacks D.L., Brown D.R., et al. Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major. J. Exp. Med. 186(7):1997;1137-1147
10. Handman E., Noormohammadi A.H., Curtis J.M., Baldwin T., Sjolander A. Therapy of murine cutaneous leishmaniasis by DNA vaccination. Vaccine. 18(26):2000;3011-3017
11. Serezani C.H.C., Franco A.R., Wajc M., et al. Evaluation of the murine immune response to Leishmania meta 1 antigen delivered as recombinant protein or DNA vaccine. Vaccine. 20(31-32):2002;3755-3763
12. Iborra S., Soto M., Carrion J., et al. The Leishmania infantum acidic ribosomal protein P0 administered as a DNA vaccine confers protective immunity to Leishmania major infection in BALB/c mice. Infect. Immun. 71(11):2003;6562-6572
13. Mendez S., Gurunathan S., Kamhawi S., et al. The potency and durability of DNA- and protein-based vaccines against Leishmania major evaluated using low-dose, intradermal challenge. J. Immunol. 166(8):2001;5122-5128
14. Rafati S., Salmanian A.H., Taheri T., Vafa M., Fasel N. A protective cocktail vaccine against murine cutaneous leishmaniasis with DNA encoding cysteine proteinases of Leishmania major. Vaccine. 19(2526):2001;3369-3375
15. Piedrafita D., Xu D., Hunter D., Harrison R.A., Liew F.Y. Protective immune responses induced by vaccination with an expression genomic library of Leishmania major. J. Immunol. 163(3):1999;1467-1472
16. Melby P.C., Ogden G.B., Flores H.A., et al. Identification of vaccine candidates for experimental visceral leishmaniasis by immunization with sequential fractions of a cDNA expression library. Infect Immun. 68(10):2000;5595-5602
17. Probst P., Stromberg E., Ghalib H.W., et al. Identification and characterization of T cell-stimulating antigens from Leishmania by CD4 T cell expression cloning. J. Immunol. 166(1):2001;498-505
18. de Carvalho L.P., Soto M., Jeronimo S., et al. Characterization of the immune response to Leishmania infantum recombinant antigens. Microbes Infect. 5(1):2003;7-12
19. Soto M., Requena J.M., Quijada L., et al. Mapping of the linear antigenic determinants from the Leishmania infantum histone H2A recognized by sera from dogs with leishmaniasis. Immunol. Lett. 48(3):1995;209-214
20. Soto M., Requena J.M., Quijada L., et al. Characterization of the antigenic determinants of the Leishmania infantum histone H3 recognized by antibodies elicited during canine visceral leishmaniasis. Clin. Exp. Immunol. 106(3):1996;454-461
21. Soto M., Requena J.M., Quijada L., et al. Antigenicity of the Leishmania infantum histones H2B and H4 during canine viscerocutaneous leishmaniasis. Clin. Exp. Immunol. 115(2):1999;342-349
22. Maalej I.A., Chenik M., Louzir H., et al. Comparative evaluation of ELISAs based on ten recombinant or purified Leishmania antigens for the serodiagnosis of Mediterranean visceral leishmaniasis. Am. J. Trop. Med. Hyg. 68(3):2003;312-320
23. Soto M., Requena J.M., Gomez L.C., Navarrete I., Alonso C. Molecular characterization of a Leishmania donovani infantum antigen identified as histone H2A. Eur. J. Biochem. 205(1):1992;211-216
24. Soto M., Requena J.M., Morales G., Alonso C. The Leishmania infantum histone H3 possesses an extremely divergent N-terminal domain. Biochim. Biophys. Acta. 1219(2):1994;533-535
25. Soto M., Quijada L., Alonso C., Requena J.M. Histone synthesis in Leishmania infantum is tightly linked to DNA replication by a translational control. Biochem. J. 346(1):2000;99-105
26. Shi P.Y., Maizels N., Weiner A.M. Recovery of soluble, active recombinant protein from inclusion bodies. Biotechniques. 23(6):1997;1036-1038
27. Buffet P.A., Sulahian A., Garin Y.J., Nassar N., Derouin F. Culture microtitration: a sensitive method for quantifying Leishmania infantum in tissues of infected mice. Antimicrob Agents Chemother. 39(9):1995;2167-2168
28. Gurunathan S., Wu C.Y., Freidag B.L., Seder R.A. DNA vaccines: a key for inducing long-term cellular immunity. Curr. Opin. Immunol. 12(4):2000;442-447
29. Requena J.M., Alonso C., Soto M. Evolutionarily conserved proteins as prominent immunogens during Leishmania infections. Parasitol Today. 16(6):2000;246-250
30. Chang K.P., Reed S.G., McGwire B.S., Soong L. Leishmania model for microbial virulence: the relevance of parasite multiplication and pathoantigenicity. Acta. Trop. 85(3):2003;375-390
31. Solioz N., Blum-Tirouvanziam U., Jacquet R., et al. The protective capacities of histone H1 against experimental murine cutaneous leishmaniasis. Vaccine. 18(910):1999;850-859
32. Masina S., Gicheru M.M., Demotz S.O., Fasel N.J. Protection against cutaneous leishmaniasis in outbred vervet monkeys using a recombinant histone H1 antigen. J. Infect Dis. 188(8):2003;1250-1257
33. Coler R.N., Skeiky Y.A.W., Bernards K., et al. Immunization with a polyprotein vaccine consisting of the T-cell antigens thiol-specific antioxidant, Leishmania major stress-inducible protein 1 and Leishmania elongation initiation factor protects against leishmaniasis. Infect. Immun. 70(8):2002;4215-4225